KalVista Pharmaceuticals, Inc. (KALV) Retained Earnings (Accumulated Deficit) USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
KalVista Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending January 31, 2024 was -$425 M, a 34.2% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 -$425 M -$108 M -34.2% Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$396 M -$101 M -34% Oct 31, 2023 10-Q 2023-12-07
Q2 2023 -$368 M -$95.2 M -34.8% Jul 31, 2023 10-Q 2023-09-07
Q1 2023 -$343 M -$92.9 M -37.1% Apr 30, 2023 10-Q 2024-03-11
Q4 2022 -$317 M -$90.7 M -40.1% Jan 31, 2023 10-Q 2023-03-09
Q3 2022 -$295 M -$91.9 M -45.1% Oct 31, 2022 10-Q 2022-12-08
Q2 2022 -$273 M -$89.3 M -48.5% Jul 31, 2022 10-Q 2022-09-08
Q1 2022 -$250 M -$82.3 M -49.1% Apr 30, 2022 10-K 2023-07-10
Q4 2021 -$226 M -$73.2 M -47.9% Jan 31, 2022 10-Q 2022-03-10
Q3 2021 -$204 M -$60.8 M -42.5% Oct 31, 2021 10-Q 2021-12-09
Q2 2021 -$184 M -$51.5 M -38.9% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 -$168 M -$46.2 M -38% Apr 30, 2021 10-K 2022-07-07
Q4 2020 -$153 M -$37.9 M -32.9% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 -$143 M -$27.8 M -24.2% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 -$132 M -$32.6 M -32.7% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 -$122 M -$29.1 M -31.5% Apr 30, 2020 10-K 2021-07-13
Q4 2019 -$115 M -$31.1 M -37% Jan 31, 2020 10-Q 2020-03-10
Q3 2019 -$115 M -$35 M -43.8% Oct 31, 2019 10-Q 2020-03-10
Q2 2019 -$99.8 M -$23.1 M -30.2% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 -$92.5 M -$20.8 M -29% Apr 30, 2019 10-K 2020-07-01
Q4 2018 -$84 M -$12.9 M -18.2% Jan 31, 2019 10-Q 2019-03-14
Q3 2018 -$80 M -$14.2 M -21.6% Oct 31, 2018 10-Q 2018-12-14
Q2 2018 -$76.7 M -$15.9 M -26.2% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 -$71.7 M -$15.8 M -28.3% Apr 30, 2018 10-K 2019-07-16
Q4 2017 -$71 M -$19.4 M -37.5% Jan 31, 2018 10-Q 2018-03-16
Q3 2017 -$65.8 M +$23.2 M +26.1% Oct 31, 2017 10-Q 2017-12-14
Q2 2017 -$60.8 M +$25.8 M +29.8% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 -$55.9 M +$23.4 M +29.5% Apr 30, 2017 10-K 2018-07-30
Q4 2016 -$51.7 M +$21 M +28.9% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 -$89 M -$22 M -32.9% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$86.6 M -$24.6 M -39.7% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 -$79.2 M -$26.3 M -49.6% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$72.6 M -$24.8 M -52% Dec 31, 2015 10-Q 2016-11-08
Q3 2015 -$67 M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$62 M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$53 M Mar 31, 2015 10-Q 2015-05-21
Q4 2014 -$47.8 M Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.